跳至主要内容
临床试验/CTRI/2022/07/044416
CTRI/2022/07/044416已完成2 期

A randomized open labelled controlled clinical study to evaluate the efficacy of Kusumik Varti Anjana in the management of Dwitiya Patalagata Timira with special reference to Presbyopia

Dr Rashmi M Patil0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients aged between 35 to 50 years having symptoms of Dwitiya patalagata timira (Presbyopia) irrespective of age, gender, occupation, religion and socio-economic status.
  • 2. Subjects willing to sign the informed consent.

排除标准

  • 1.Subjects having Hypermetropia & Opthalmoplegia.
  • 2.Subjects having Ocular disease secondary to systemic illness.
  • 3.Subjects having damaged lens, zonules or ciliary muscle due to any trauma.
  • 4.Subjects diagnosed with any stage of Cataract.
  • 5.Subjects presenting with pseudophakia.
  • 6.Other ocular diseases leading to visual disturbances like ulcers, opacities or degenerative growths.

研究者

发起方
Dr Rashmi M Patil

相似试验